Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus fluoxetine in adults with type 2 diabetes mellitus and depression
IRCT20150630022991N9Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in major depressive disorder (MDD) comparing Sertraline with Fluoxetine (2 arms). Primary endpoint: Blood glucose status. Started Sep 2017; status: completed.
02
Drugs
sertralinefluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20150630022991N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150630022991N9.